Evidence Partners and Akra Team collaborate to help medical device companies
by CM Staff
The partnership will apply technology called the DistillerSR, which automates the management of literature collection, triage and assessment using AI and intelligent workflows.
OTTAWA — Evidence Partners Inc. has announced a collaboration with Akra Team to deliver end-to-end consulting services to help medical device companies complete EU MDR and IVDR notified body submissions.
Akra Team is a German-based strategic regulatory consultancy. Evidence Partners says it anticipates the partnership will help improve workflows, the management of regulatory risk, literature reviews and submissions for different device types.
Reported industry expert Dr. Bassil Akra heads the Akra Team, which provides consulting services to global companies manufacturing medical and in-vitro diagnostic devices.
A platform called the DistillerSR automates the management of literature collection, triage and assessment using AI and intelligent workflows to reduce the time it takes to complete a systematic literature review.
“Medical device and in-vitro diagnostic device manufacturers are facing tremendous hurdles in securing timely regulatory approvals for their products in the EU,” said Peter O’Blenis, CEO of Evidence Partners in a statement.
“This new combined offering gives regulatory teams a more efficient toolkit to create and maintain their regulatory dossiers while also providing the confidence that their submissions will not be held up in audits. With so much at stake, our collective service provides a hyper-charged pathway to help our customers get their submissions right the first time, by integrating market-leading regulatory expertise and DistillerSR as the best-of-breed literature review platform.”
